The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of an incarcerated umbilical hernia.
It was reported that after implant, the patient experienced recurrence, numerous adhesions, old mesh incorporated some of scar tissue, subacute fascial wound dehiscence with exposed viscera, right edge of mesh had pulled off of fascia and exposed bowel and mesentery at periumbilical wound, dense abdominal wall adhesions where the bowel had subacutely eviscerated, dense intraabdominal adhesions, serosal tears, mesh had odor and foul-smelling, bowel leak from a distal jejunal enterotomy with significant succus in abdomen, old incorporated mesh that was seeding the sinus tract, infection, ascites, abscess, and purulent discharge.
Post-operative patient treatment included recurrent incarcerated incisional hernia repair with mesh, incarcerated omentum was reduced, excised bulk of the old mesh, removal of old infected mesh, incarcerated tissue was reduced, extensive lysis of adhesions required to free anterior abdominal wall and mobilize small bowel off surgical site and mesh, repair to serosal tears, segmental small bowel resection, debridement of anterior abdominal wall, excision of intraperitoneal and anterior abdominal wall mesh, vac dressing applied, abdominal washout, abdominal wall closure with mesh, abdominal re-exploration for postoperative sepsis, evacuated turbid fluid sitting in central lower abdomen, incision and drainage of right retroperitoneal abscess as well as thick, tan, purulent fluid was obtained and lastly, ventral/incisional hernia repair with mesh.
|